Fundraising Fox株式会社Trans Chromosomics
1 known investors
Find your way into 株式会社Trans Chromosomics
Sign up to see every warm intro you have to 株式会社Trans Chromosomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社Trans Chromosomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Trans Chromosomics develops drug-discovery technologies based on artificial chromosome engineering, including fully human antibody-producing mice and disease model animals for human and animal medicine. Its work supports therapeutic antibody development and related research applications.
Investors · 1
Frequently asked questions
- What does 株式会社Trans Chromosomics do?
- Trans Chromosomics develops drug-discovery technologies based on artificial chromosome engineering, including fully human antibody-producing mice and disease model animals for human and animal medicine. Its work supports therapeutic antibody development and related research applications.
- Who are 株式会社Trans Chromosomics's investors?
- 株式会社Trans Chromosomics's investors include TNP Partners Corporation.